- Angiotensin converting enzyme inhibitors remain the first treatment of choice
-
Oh PC, Sakuma I, Hayashi T, Koh KK
- KMID: 2373798
- Korean J Intern Med.
- 2016 Mar;31(2):237-241.
- doi: 10.3904/kjim.2016.026
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Hypertriglyceridemia and Cardiovascular Diseases: Revisited
-
Han SH, Nicholls S, Sakuma I, Zhao D, Koh KK
- KMID: 2344463
- Korean Circ J.
- 2016 Mar;46(2):135-144.
- doi: 10.4070/kcj.2016.46.2.135
Residual cardiovascular risk and failure of high density lipoprotein cholesterol raising treatment have refocused interest on targeting hypertriglyceridemia. Hypertriglyceridemia, triglyceride-rich lipoproteins, and remnant cholesterol have demonstrated to be important risk... -
- CITED
-
- Close
- SHARE
-
- Close
- Switching from Conventional Fibrates to Pemafibrate Has Beneficial Effects on the Renal Function of Diabetic Subjects with Chronic Kidney Disease
-
Izumihara R, Nomoto H, Kito K, Yamauchi Y, Omori K, Shibayama Y, Yanagiya S, Miya A, Kameda H, Cho KY, Nagai S, Sakuma I, Nakamura A, Atsumi T, on Behalf of the PARM-T2D Study Group
- KMID: 2555778
- Diabetes Metab J.
- 2024 May;48(3):473-481.
- doi: 10.4093/dmj.2023.0370
Background: Fibrates have renal toxicity limiting their use in subjects with chronic kidney disease (CKD). However, pemafibrate has fewer toxic effects on renal function. In the present analysis, we evaluated... -
- CITED
-
- Close
- SHARE
-
- Close
- Combining Potent Statin Therapy with Other Drugs to Optimize Simultaneous Cardiovascular and Metabolic Benefits while Minimizing Adverse Events
-
Koh KK, Sakuma I, Shimada K, Hayashi T, Quon MJ
- KMID: 2392877
- Korean Circ J.
- 2017 Jul;47(4):432-439.
- doi: 10.4070/kcj.2016.0406
Hypercholesterolemia and hypertension are among the most important risk factors for cardiovascular (CV) disease. They are also important contributors to metabolic diseases including diabetes that further increase CV risk. Updated... -
- CITED
-
- Close
- SHARE
-
- Close
